165047-24-5 Usage
Chemical Properties
Clear colorless to light yellow liquid
Uses
Different sources of media describe the Uses of 165047-24-5 differently. You can refer to the following data:
1. It is a reactant in the enantioselective synthesis of (R)-selegiline, an anti-Parkinson's drug, (S)-benzphetamine, an anti-obesity agent, and (S)-sitagliptin, an anti-diabetic drug.
2. 2,4,5-Trifluorobenzaldehyde may be used in the synthesis of:bis(2,4,5-trifluorophenyl)methanone8-phenyl-7-tosyl-1-(2,4,5-trifluorophenyl)octahydro-1H-pyrano[3,4-c] pyridine(E)-4-methoxy-N′-(2,4,5-trifluorobenzylidene)-benzohydrazide monohydrate
Check Digit Verification of cas no
The CAS Registry Mumber 165047-24-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,5,0,4 and 7 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 165047-24:
(8*1)+(7*6)+(6*5)+(5*0)+(4*4)+(3*7)+(2*2)+(1*4)=125
125 % 10 = 5
So 165047-24-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H2ClFN4/c6-3-2-4(9-1-8-2)11-5(7)10-3/h1H,(H,8,9,10,11)
165047-24-5Relevant articles and documents
(Oxime)carbamoyl fatty acid amide hydrolase inhibitors
-
, (2008/06/13)
The present invention relates to novel oxime carbamyl derivatives and pharmaceutical compositions comprising said derivatives which inhibit fatty acid amide hydrolase. These pharmaceutical compositions are useful for the treatment of conditions which can be effected by inhibiting fatty acid amide hydrolase including, but not limited to, neuropathic pain, emesis, anxiety, altering feeding behaviors, movement disorders, glaucoma, brain injury, and cardiovascular disease.
